BIEI - Premier Biomedical, Inc.
| Previous Close | 0.0023 |
| Open | 0.0023 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0019 - 0.0053 |
| 52 Week Range | 0.0002 - 0.0455 |
| Volume | 287,383,708 |
| Avg. Volume | 42,577,741 |
| Market Cap | 934,804 |
| Beta (5Y Monthly) | -0.26 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0680 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
Covid-19 Treatment Provisional Patent Application Filed; Premier Biomedical, Inc. Granted Global Commercial Rights
JACKSON CENTER, PA / ACCESSWIRE / March 23, 2020 / Premier Biomedical, Inc. (OTC PINK: BIEI ) announced today the filing of a provisional patent application, Method for Treating and Curing Covid-19 Infection ...
- ACCESSWIRE
Premier Biomedical Announces Evolution of Business Focus and Name Change
Name Change to Better Reflect New Products and Company Direction JACKSON CENTER, PA / ACCESSWIRE / November 14, 2019 / Premier Biomedical, Inc. (OTCQB: BIEI ) announced today a change in the company's ...
- Newsfile
Premier Biomedical, Inc. CEO, William Hartman, Addresses Current Challenges with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - October 21, 2019) - The Stock Day Podcast welcomed Premier Biomedical, Inc. (OTCQB: BIEI) ("the Company"), a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases in humans. President and CEO, William Hartman, joined Stock Day host Everett Jolly. Jolly began the interview by noting that the Company's stock has been struggling, and asked Hartman to give listeners an update on ...
- GuruFocus.com
Largest Insider Trades of the Week
Insiders pile on shares of Kraft Heinz, shed Overstock Continue reading...
- ACCESSWIRE
MoneyTV with Donald Baillargeon, 9/20
HOLLYWOOD, CA / ACCESSWIRE / September 20, 2019 / Hemp cigarettes, public company audits, CBD in China, pain relief patches, Belize tree plantation, news media irresponsibility; this week on MoneyTV with ...
- Newsfile
Premier Biomedical, Inc. Joins The Stock Day Podcast to Announce The Release of Its Anti-Addiction Patch(TM)
Phoenix, Arizona--(Newsfile Corp. - September 17, 2019) - The Stock Day Podcast welcomed Premier Biomedical, Inc. (OTCQB: BIEI) ("the Company"), a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases in humans. President and CEO, William A. Hartman, joined Stock Day host Everett Jolly. Jolly began the interview by noting that a Co-Founder of the Company, Dr. Mitchell Felder, has purchased two million shares of ...
- Newsfile
CEO, William Hartman, Joins The Stock Day Podcast to Discuss Their New Joint Venture and Upcoming Anti-Addiction Patch
Phoenix, Arizona--(Newsfile Corp. - August 12, 2019) - The Stock Day Podcast welcomed Premier Biomedical, Inc. (OTCQB: BIEI) ("the Company"), a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases in humans. President and CEO, William Hartman, joined Stock Day host Everett Jolly. To begin the interview, Jolly commented on the Company's recent announcements and asked for an update on their current projects. Hartman explained ...
- ACCESSWIRE
MoneyTV with Donald Baillargeon, 8/9
HOLLYWOOD, CA / ACCESSWIRE / August 9, 2019 / CBD industry, water solutions, China, identity theft; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program ...
- ACCESSWIRE
Premier Biomedical Signs Joint Venture Agreement With New Earth Development, RushNet Inc., and XYZ Hemp, Inc. to Market New Anti-Addiction Patch
JACKSON CENTER, PA / ACCESSWIRE / July 30, 2019 / Premier Biomedical, Inc. (OTCQB: BIEI) announced today the signing of an agreement forming a joint venture with New Earth Development Corporation, RushNet, Inc., and XYZ Hemp, Inc. to manufacture, market and sell a revolutionary Anti-Addiction Patch containing Premier Biomedical’s patented natural and synthetic formulation. The product will be based on the topical pain relieving patch technology currently marketed by Premier Biomedical. Dr. Mitchell Felder, Chairman of the Board of Premier Biomedical, stated, “The Anti-Addiction Patch is a proprietary blend of natural components, including hemp oil extracts and a patented combination (US Pat.
- ACCESSWIRE
MoneyTV with Donald Baillargeon, 5/24
HOLLYWOOD, CA / ACCESSWIRE / May 24, 2019 / Burgeoning CBD industry, Chinese investors, solar power, water industry, beware Biden's hands; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally ...
